| Screening Guideline |
Source |
| Cancer Screening |
| Breast Cancer Screening |
American Cancer Society
American College of Obstetricians and Gynecologists
American College of Radiology
National Cancer Institute
US Preventive Services Task Force |
| Age 20-40 = clinical breast exam every 2 years* |
| Age 40-49 = clinical breast exam and mammography 1-2 years* |
| Age 50-70 = clinical breast exam and mammography annually |
| * Dialogue between patient and physician should determine a patients
desires, risks, and needs for yearly screening versus every 2 years. |
| Cervical Cancer Screening |
| Age 18 and older = every 1-3 years based on dialogue with physician |
American Cancer Society
American College of Obstetricians and Gynecologists
National Cancer Institute
US Preventive Services Task Force |
| Colorectal Cancer Screening |
When to Begin Screening
• Begin screening for colorectal cancer at age 50.
• Individuals who are- at high risk for developing colon cancer should be
screened earlier and more frequently in consultation with a specialist in
this area.
|
American Cancer SocietyColorado Clinical Guidelines Collaborative |
When to Stop Screening
• All screening should be individualized based on age, medical
condition, and comorbidity, and may not be appropriate for individuals
with a life expectancy of less than 5 years. Thus, screening may be
discontinued late in life. |
Screening Options
• FOBT yearly
• Flexible sigmoidoscopy every 5years (every 10 years may also be
effective), with or without FOBT every year
• Colonoscopy every 10 years
• Double contrast barium enema every 5 years |
Prostate Cancer Screening
• Beginning at age 40, counsel about the known risks and unknown benefits
of screening for prostate cancer.
• If screening is performed, screen with DRE and PSA. It is most helpful
among young, relatively healthy men those with a life expectancy of
greater than 10 years. |
American Cancer Society
US Preventive Services Task Force |
| Immunizations |
Adult Tetanus-Diphtheria (Td) Vaccine
• Adults, including pregnant women with uncertain history of a complete
primary vaccination series, should receive a primary series of Td.
• Adults who have completed the series should receive a Td booster every
10 years.
• Persons with major wounds may require a booster if S years have elapsed
since the last dose. |
Advisory Committee on Immunization Practices
American College of Obstetricians and Gynecologists
Colorado Department of Public Health and Environment
|
Childhood Immunizations
• Recommended Childhood Immunization Schedule, 2005
• Recommended Childhood and Adolescent Catch-Up Schedule, 2005 |
Advisory Committee on Immunization Practices
American Academy of Pediatrics
American Academy of Family Physicians |
Influenza Vaccine
• Persons at increased risk for complications of influenza:
• age 65 and older
• residents of chronic care facilities
• adults and children with:
• chronic disorders of the pulmonary and cardiovascular systems
• chronic metabolic diseases (including diabetes)
• renal dysfunction
• hemoglobinopathies
• immunosuppression (including immunosuppression caused by
medications or HIV)
• children and adolescents (age 6 months-18 years) receiving long-term
aspirin therapy
• women who will be pregnant during the influenza season
• children age 6-23 months
• Household members or caregivers of persons at high risk
• Health care workers
• Healthy people age 50-64
• Anyone who wants to reduce the likelihood of becoming ill with influenza |
Advisory Committee on Immunization Practices
American Academy of Family Physicians
American Academy of Pediatrics |
Pneumococcal Conjugate Vaccine (Children under 5 years)
• Children age 2-23 months
• Children age 24-59 months considered high risk, such as:
• children with sickle cell disease
• children with HIV infection
• children who are immunocompromised
• children with chronic illness
• Alaskan Natives, Native Americans, and African Americans
• children who have or will receive cochlear implants |
Advisory Committee on Immunization Practices
American Academy of Pediatrics |
Pneumococcal Polysaccharide Vaccine (Children 5 Years + and Adults) • Age 65+
• Institutionalized persons age 50+
• Immunocompetent persons age 5+ who are at increased risk for illness and
death associated with pneumococcal disease because of chronic illness
• Age 5 + with functional or anatomic asplenia, chronic cardiac or
pulmonary disease, or diabetes
• Age 5± living in environment in which the risk for disease is high
• Immunocompromised persons age 5+ who are at high risk for infection
• Age 5+ with cochlear implants
• Age 5+ planning to receive a cochlear implant should be up to date on age-
appropriate pneumococcal vaccination at least 2 weeks before surgery, if
possible |
Advisory Committee on Immunization Practices
|
| Well-Care Guidelines |
Well-Care Guidelines for Infants
• Recommended intervals: I and 4weeks, 2 months, 4 months, 6 months, 9
months, 12 months, 15 months, 18 months, 24 months |
American Academy of Pediatrics
American Academy of Family Physicians |
Well-Care Guidelines for Children and Adolescents
• Age 3-5 annually
• Age 6-10 every two years
• Age 11-21 annually |
American Academy of Family Physicians
American Academy of Pediatrics |
Well-Care Guidelines for Adults
• Age 21-40 = every 5 years (if healthy)
• Age 40+ = every 1-3 years |
American Academy of Family Physicians
US Preventive Services Task Force |
